GO
Loading...

Enter multiple symbols separated by commas

Novartis Gets EU OK for New Flu Vaccine

Swiss drugmaker Novartis said Wednesday it has received European Union approval for flu vaccine Optaflu.

Iceland and Norway also have approved Optaflu for use in vaccination against seasonal influenza, Novartis said, adding that its use of proprietary cell culture technology could help in the event of flu pandemic crisis.

"Optaflu marks the first major innovation in influenza vaccine manufacturing in over 50 years," said Dr. Joerg Reinhardt, chief executive of Novartis vaccines and diagnostics.

Reinhardt said the vaccine would provide a "more flexible and reliable production process," helping to meet demand for seasonal flu treatments and vaccines in case of a pandemic.

Health officials around the world have been preparing in case the bird flu virus that has killed at least 190 people since it began ravaging Asian poultry stocks in 2003 mutates into a form that spreads more easily between humans. The World Health Organization has warned that a pandemic could kill hundreds of thousands around the globe.

Novartis said Optaflu is expected to be available in Germany and Austria for next winter's flu season. It will be available in the other 25 EU countries by the 2008-2009 season.

The company said it will probably seek U.S. regulatory approval next year.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Don't Miss

  • Piper Hoppe, 10, from Minnetonka, Minnesota, holds a sign at the doorway of River Bluff Dental in Bloomington, Minnesota, on July 29, 2015, during a protest against Cecil's killing.

    The U.S. Fish and Wildlife Service has been trying to find the man who shot a lion in Zimbabwe, but he is not responding.

  • Donald Trump

    From one real estate mogul about another: Don't underestimate Republican presidential candidate Donald Trump.

  • Rifle sight

    Hackers were able to exploit a sniper rifle's vulnerabilities and change the gun's target, according to Wired.

U.S. Video

  • What market volatility is signaling...

    Mike Santoli, Yahoo finance columnist, and Eric Cantor, Moelis & Co., vice chair, discuss the market's wild swings and whether regulations have hampered growth on Wall Street. It's time to find another way to do it, says Cantor.

  • Link between health care and economy: UHS CEO

    Alan Miller, Universal Health Services CEO, discusses how rising health care costs and an aging population are impacting the health service sector.

  • It's still a central banker's world

    Investors shouldn't expect pro-growth fiscal policies to overshadow the Federal Reserve any time soon, Russell Investment's Stephen Wood said.